Understanding molecular landscape of endometrial cancer through next generation sequencing: what we have learned so far?
Endometrial cancer is among the most common gynecological cancers affecting women worldwide. Despite the early detection and rather high overall survival rate, around 20% of the cases recur with poor prognosis. The Next Generation Sequencing (NGS) technology, also known as massively parallel sequenc...
Main Authors: | SITI SYAZANI SUHAIMI, NURUL SYAKIMA AB MUTALIB, RAHMAN JAMAL |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00409/full |
Similar Items
-
Endometrial receptivity: The journey so far
by: Osazee K, et al.
Published: (2019-02-01) -
Genomic Comparison of Endometrioid Endometrial Carcinoma and Its Precancerous Lesions in Chinese Patients by High-Depth Next Generation Sequencing
by: Yao Wang, et al.
Published: (2019-03-01) -
Identification of Lynch Syndrome in Patients with Endometrial Cancer Based on a Germline Next Generation Sequencing Multigene Panel Test
by: Yoo-Na Kim, et al.
Published: (2022-07-01) -
Targeted Treatment of Advanced Endometrial Cancer: Focus on Pembrolizumab
by: El-ghazzi N, et al.
Published: (2023-06-01) -
Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy
by: Soberanis Pina P, et al.
Published: (2024-03-01)